Core Viewpoint - The A-share market showed mixed performance with the Shanghai Composite Index rising over 1% in early trading, indicating positive investor sentiment despite some sector declines [1]. Market Performance - The Shanghai Composite Index closed at 4069.38 points, up 1.14% - The Shenzhen Component Index closed at 13940.24 points, up 0.81% - The ChiNext Index closed at 3293.18 points, down 0.04% [1]. Sector Performance Top Performing Sectors - Insurance sector increased by 4.91% with a total trading volume of 292.22 million hands and a net inflow of 15.55 billion - Small metals sector rose by 4.67% with a trading volume of 954.96 million hands and a net inflow of 37.26 billion - Energy metals sector gained 3.72% with a trading volume of 384.15 million hands and a net inflow of 18.67 billion [2]. Underperforming Sectors - Communication equipment sector decreased by 0.68% with a trading volume of 1889.06 million hands and a net outflow of 77.51 billion - Components sector fell by 0.65% with a trading volume of 929.90 million hands and a net outflow of 31.50 billion - Beauty care sector declined by 0.25% with a trading volume of 157.47 million hands and a net outflow of 0.42 billion [2].

Group 1 - The report highlights that the company plans to issue convertible bonds to raise up to 878 million RMB for investment in new projects, including a 5000 tons/year vitamin K3 and 74,000 tons/year chromium green project, and a 500,000 tons/year sulfuric acid and 50,000 tons/year chromium powder project [3][5] - The innovative "vitamin K3 co-production chromium green" process is expected to break the production bottleneck of chromium green, utilizing chromium-containing waste from vitamin K3 production to create high-quality chromium green, thus enhancing environmental performance and operational results [5][6] - The company has successfully acquired land for the new project in Chongqing, with a total investment of approximately 3 billion RMB, which will significantly drive long-term growth [7][8] Group 2 - The report indicates that the chromium market is experiencing a bullish cycle, with the average price of metallic chromium rising from 67,500 RMB/ton to 82,000 RMB/ton, and chromium oxide green prices increasing from 29,500 RMB/ton to 36,500 RMB/ton [9][10] - The downstream demand for chromium is expected to grow due to the increasing needs in high-temperature alloys used in military and civilian aircraft, gas turbines, and other high-end equipment, which will further boost the market demand for chromium and its raw materials [5][10] - The company is projected to benefit from the chromium market cycle, with revenue forecasts for 2025, 2026, and 2027 estimated at 43.63 billion RMB, 66.42 billion RMB, and 72.52 billion RMB, respectively, alongside net profits of 6.04 billion RMB, 11.96 billion RMB, and 13.70 billion RMB [11]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is expected to achieve a significant year-on-year increase in net profit for 2025, with estimates ranging from 96 million to 110 million yuan, representing a growth of 50.60% to 72.56%. The adjusted net profit forecast for 2025-2027 is 110 million, 167 million, and 221 million yuan respectively, with corresponding EPS of 1.31, 1.98, and 2.63 yuan. The current stock price corresponds to a PE ratio of 25.2, 16.6, and 12.5 times for the years 2025, 2026, and 2027 [4][8] Summary by Relevant Sections Financial Performance - The company forecasts a revenue of 1.035 billion yuan for 2025, with a year-on-year growth of 13.7%. The net profit margin is expected to improve to 10.6% in 2025, with a projected net profit of 110 million yuan, reflecting a 72.0% increase compared to the previous year [8][11] Potassium Salt Industry - The domestic potassium carbonate industry is characterized by an oligopoly with limited players and no significant expansion plans in the short term. The company, as a leading domestic producer, has an annual production capacity of 85,000 tons of light potassium carbonate. The anticipated integration of competitors facing financial difficulties may further enhance profitability in the industry as demand steadily increases [5] Veterinary Medicine Sector - The global market demand for Amprolium hydrochloride is estimated to be between 1,200 to 1,500 tons annually, with the company holding a production capacity of 600 tons per year. A planned expansion project is expected to increase capacity to 800 tons per year by June 2026. Geopolitical tensions in the Middle East may disrupt supply from competitors, allowing the company to benefit from increased market share [6] PEEK Project - The company plans to invest 193 million yuan to establish a production line for 2,000 tons of PEEK and key intermediates. This project aims to create a complete industrial chain from fluorobenzene to fluoroketone and PEEK, leveraging technical support from renowned universities. This investment is expected to open up long-term growth opportunities for the company [7]

1月5日，沪指12连阳重回4000点。截至收盘，沪指涨1.38%，深证成指涨2.24%，创业板指涨2.85%。 高位股方面 锋龙股份7连板，德力股份8天4板，雷科防务4连板，中国卫通、北斗星通5天3板，勘设股份4天3板，南 兴股份、友邦吊顶3连板，国晟科技、航天机电、海格通信、凯瑞德4天2板，东方通信3天2板。 | 代码 | | 名称 | 涨幅 | 现价 | 换手 涨停分析 儿大儿板� | | --- | --- | --- | --- | --- | --- | | 1 | 002931 | 锋龙股份 | +10.00% | 34.87 | 0.17% 优必选拟入主+机器人+园... 7连板 | | 2 | 002571 | 德力股份 | +10.03% | 12.94 | 5.68% 翼元航空入主+商业航天+... 8天4板 | | 3 | 002413 | 雷科防务 | +10.04% | 13.81 | 2.16% 商业航天+卫星遥感+量米... 4连板 | | ব | 601698 | 中国 1 1 用 | +9.99% | 39.30 | 7.03% 商业航天+卫星互联网+央 ... 5天3板 | ...

IPO Overview - As of January 4, 2026, there are 342 companies in the IPO queue, with 23 on the Shanghai Main Board, 46 on the Sci-Tech Innovation Board, 21 on the Shenzhen Main Board, 44 on the Growth Enterprise Market, and 208 on the Beijing Stock Exchange [1][2]. Newly Listed Companies - Five companies were newly listed between December 29, 2025, and January 4, 2026, including Inner Mongolia Shuangxin Environmental Materials Co., Ltd., Shanghai Yufan Environmental Technology Co., Ltd., Qiangyi Semiconductor (Suzhou) Co., Ltd., Suzhou Xinguangyi Electronics Co., Ltd., and Hengtong Communication Technology (Shenzhen) Co., Ltd. [3][4]. Stock Performance of Newly Listed Companies - Inner Mongolia Shuangxin Environmental Materials Co., Ltd. closed at 19.68 CNY per share, with a rise of 187.30% and a trading volume of 30.45 billion CNY [5]. - Shanghai Yufan Environmental Technology Co., Ltd. closed at 50.01 CNY per share, with a rise of 124.36% and a trading volume of 9.41 billion CNY [5]. - Qiangyi Semiconductor (Suzhou) Co., Ltd. closed at 226.01 CNY per share, with a rise of 165.61% and a trading volume of 43.45 billion CNY [6]. - Suzhou Xinguangyi Electronics Co., Ltd. closed at 71.32 CNY per share, with a rise of 225.22% and a trading volume of 17.41 billion CNY [6]. - Hengtong Communication Technology (Shenzhen) Co., Ltd. closed at 309.00 CNY per share, with a rise of 878.16% and a trading volume of 36.48 billion CNY [7]. New Counseling Record Companies - A total of 35 companies were newly recorded for counseling between December 29, 2025, and January 4, 2026, including Shenzhen Chenzhuo Technology Co., Ltd., Beijing Bimai Sports Co., Ltd., and others [8][9]. Companies Approved for Registration - Five companies received registration approval during the same period, including Dalian Meidele Industrial Automation Co., Ltd., Zhejiang Haisheng Medical Devices Co., Ltd., and others [22][23]. Companies with Terminated Reviews - Dalian Ruike Technology Co., Ltd. has terminated its IPO review [26][27].

Market Overview - The chemical raw materials sector increased by 0.52% compared to the previous trading day, with Dayang Biological leading the gains [1] - The Shanghai Composite Index closed at 4023.42, up 1.38%, while the Shenzhen Component Index closed at 13828.63, up 2.24% [1] Top Performers - Dayang Biological (stock code: 003017) closed at 32.85, with a rise of 10.01% and a trading volume of 89,600 shares, amounting to a transaction value of 288 million [1] - Zhenhua Co., Ltd. (stock code: 603067) also saw a significant increase of 10.00%, closing at 31.69 with a trading volume of 283,700 shares [1] - Aokai Co., Ltd. (stock code: 300082) rose by 9.39%, closing at 10.83 with a trading volume of 517,000 shares [1] Underperformers - Jiaxian Co., Ltd. (stock code: 920489) experienced the largest decline, falling by 10.33% to close at 16.14, with a trading volume of 92,800 shares [2] - Huatai (stock code: 001217) decreased by 5.76%, closing at 13.10 with a trading volume of 246,900 shares [2] - Boyuan Chemical (stock code: 000683) saw a decline of 1.88%, closing at 7.30 with a trading volume of 822,400 shares [2] Capital Flow - The chemical raw materials sector saw a net inflow of 318 million from main funds, while retail investors experienced a net outflow of 325 million [2][3] - Dayang Biological attracted a net inflow of 90.33 million from main funds, while retail investors had a net outflow of 52.60 million [3] - Zhenhua Co., Ltd. had a net inflow of 25.60 million from main funds, with retail investors showing a net outflow of 13.36 million [3]

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook based on the anticipated benefits from the chromium salt market cycle [14]. Core Insights - The company plans to issue convertible bonds to raise up to RMB 878 million for investment in new projects, including a 50,000 tons/year chromium powder project and a 7.4 million tons/year chromium green project, which will enhance production capacity and optimize processes [6][8]. - The innovative "Vitamin K3 co-production chromium green" process is expected to break the production bottleneck and improve the quality and stability of chromium green products, aligning with the growing demand in high-temperature alloy markets [8][11]. - The company is well-positioned to benefit from the increasing demand for chromium salts driven by the aerospace and military sectors, with a projected supply-demand gap of 340,900 tons by 2028 [11]. Financial Projections - Revenue forecasts for 2025, 2026, and 2027 are estimated at RMB 43.63 billion, RMB 66.42 billion, and RMB 72.52 billion, respectively, with corresponding net profits of RMB 6.04 billion, RMB 11.96 billion, and RMB 13.70 billion [11][12]. - The projected P/E ratios for the same years are 34, 17, and 15 times, reflecting a favorable valuation as the company is expected to benefit from the chromium salt market cycle [11][12]. Market Performance - The company's stock has shown significant growth, with a 12-month performance increase of 221.5%, outperforming the Shanghai and Shenzhen 300 index [5]. - As of December 31, 2025, the company's market capitalization stands at RMB 20.477 billion, with a current stock price of RMB 28.81 [5].

资料显示，浙江大洋生物科技集团股份有限公司位于浙江省杭州市建德市大洋镇朝阳路22号，成立日期 1976年1月1日，上市日期2020年10月26日，公司主营业务涉及从事无机盐、兽用原料药等化学原料产品 的生产和销售。主营业务收入构成为：无机盐产品69.91%，兽用原料药18.35%，含氟化学品7.46%，其 他产品4.28%。 从基金十大重仓股角度 数据显示，鹏华基金旗下1只基金重仓大洋生物。鹏华稳健回报混合A（009023）三季度持有股数47.16 万股，占基金净值比例为3.43%，位居第十大重仓股。根据测算，今日浮盈赚取约82.53万元。 鹏华稳健回报混合A（009023）成立日期2020年3月27日，最新规模3.27亿。今年以来收益88.14%，同 类排名190/8155；近一年收益88.14%，同类排名190/8155；成立以来收益109.01%。 1月5日，大洋生物涨5.86%，截至发稿，报31.61元/股，成交3363.97万元，换手率1.57%，总市值26.55 亿元。 鹏华稳健回报混合A（009023）基金经理为胡颖。 截至发稿，胡颖累计任职时间4年52天，现任基金资产总规模14.68亿元，任职 ...

甘肃省兰州市中级人民法院已于2025年12月26日裁定批准《甘肃亚太实业发展股份有限公司重整计 划》，公司进入重整计划执行阶段。公司以现有总股本323,270,000股为基数，按每10股转增5股实施资 本公积金转增股本，转增后总股本将增至484,905,000股。转增股份全部用于引入重整投资人，不向原出 资人分配。 ST亚太股票（证券简称：ST亚太，证券代码：000691）于2025年12月31日开市起停牌一天，2026年1月 5日开市起复牌。此次停牌系因实施资本公积金转增股本，股权登记日为2025年12月31日，转增上市日 为2026年1月5日。 截至2025年12月30日收盘，*ST亚太（000691）报收于9.1元，较上周的9.3元下跌2.15%。本周，*ST亚 太12月29日盘中最高价报9.67元。12月30日盘中最低价报9.0元。*ST亚太当前最新总市值29.42亿元，在 化学原料板块市值排名52/57，在两市A股市值排名4571/5181。 本周关注点 公司公告汇总 2025年12月31日，公司收到兰州中院裁定，终结公司重整程序。公司基本面得到改善，但因2024年末净 资产为负，股票仍被实施退市风 ...

Core Viewpoint - The December PMI indices show a significant rebound in manufacturing and non-manufacturing sectors, driven by new economic momentum and consumer goods industries, while the effects of debt reduction are easing and export resilience is supporting growth [2][3][25]. Group 1: Manufacturing Sector - The manufacturing PMI increased by 0.9 percentage points to 50.1%, marking a return to the growth threshold after nine months [2][6]. - The production and new orders indices rose by 1.7 and 1.6 percentage points to 51.7% and 50.8%, respectively [6][28]. - High-tech and equipment manufacturing sectors saw improvements, with PMIs rising by 2.4 and 0.6 percentage points to 52.5% and 50.4% [12][18]. Group 2: Consumer Goods Sector - The overall consumer goods PMI rose by 1 percentage point to 50.4%, despite a significant decline in the automotive sector PMI, which fell by 5.8 percentage points [15][25]. - The textile and apparel industry PMI increased by 4.5 percentage points to 57.5%, reflecting improvements in travel-related demand [15][25]. Group 3: Construction Sector - The construction PMI rose by 3.2 percentage points to 52.8%, indicating a recovery in building activities due to easing debt reduction pressures and the implementation of new policies [3][18]. - The new orders index in the construction sector increased by 1.3 percentage points, while the employment index slightly declined [50]. Group 4: Export and Domestic Demand - The domestic orders index rose by 1.6 percentage points to 51.1%, while the new export orders index improved by 1.4 percentage points to 49% [22][25]. - Port trade volumes increased by 0.6 percentage points year-on-year, maintaining a high level of activity [22][25].